DENTSPLY SIRONA Inc. to Post Q2 2023 Earnings of $0.45 Per Share, Jefferies Financial Group Forecasts (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) – Analysts at Jefferies Financial Group decreased their Q2 2023 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research report issued on Monday, November 21st. Jefferies Financial Group analyst B. Couillard now anticipates that the medical instruments supplier will post earnings per share of $0.45 for the quarter, down from their prior estimate of $0.49. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.96 per share. Jefferies Financial Group also issued estimates for DENTSPLY SIRONA’s FY2023 earnings at $1.80 EPS.

A number of other research analysts have also recently issued reports on the company. started coverage on DENTSPLY SIRONA in a research note on Wednesday, October 12th. They set a “hold” rating for the company. TheStreet cut DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. William Blair reissued an “underperform” rating on shares of DENTSPLY SIRONA in a report on Tuesday, November 1st. Robert W. Baird cut their price target on DENTSPLY SIRONA to $32.00 in a report on Thursday, November 17th. Finally, Piper Sandler lowered their price objective on DENTSPLY SIRONA from $38.00 to $29.00 in a research report on Monday, November 14th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $40.70.

DENTSPLY SIRONA Trading Down 0.8 %

XRAY opened at $30.37 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.04 and a current ratio of 1.50. The business has a 50 day moving average of $29.79 and a 200-day moving average of $33.95. DENTSPLY SIRONA has a 52 week low of $26.48 and a 52 week high of $58.70.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). The firm had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $1.01 billion. DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company’s revenue for the quarter was down 8.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.68 EPS.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Parkside Financial Bank & Trust grew its stake in shares of DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 568 shares during the last quarter. Wipfli Financial Advisors LLC bought a new position in DENTSPLY SIRONA in the third quarter worth approximately $27,000. Riverview Trust Co grew its stake in DENTSPLY SIRONA by 185.6% in the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 644 shares in the last quarter. SRS Capital Advisors Inc. bought a new position in DENTSPLY SIRONA in the third quarter worth approximately $28,000. Finally, Van ECK Associates Corp bought a new position in DENTSPLY SIRONA in the second quarter worth approximately $41,000. Institutional investors own 96.00% of the company’s stock.


(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Further Reading

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.